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Abstract: Sparse representation classification achieves good results by addressing
recognition problem with sufficient training samples per subject. However, SRC
performs not very well for small sample data. In this paper, an inverse-projection
group sparse representation model is presented for breast tumor classification, which
is based on constructing low-rank variation dictionary. The proposed low-rank
variation dictionary tackles tumor recognition problem from the viewpoint of
detecting and using variations in gene expression profiles of normal and patients,
rather than directly using these samples. The inverse projection group sparsity
representation model is constructed based on taking full using of exist samples and
group effect of microarray gene data. Extensive experiments on public breast tumor
microarray gene expression datasets demonstrate the proposed technique is
competitive with state-of-the-art methods. The results of Breast-1, Breast-2 and
Breast-3 databases are 80.81%, 91.49% and 100% respectively, which are better than
the latest literature.
Keywords: Breast tumor classification, low-rank variation dictionary, inverse
projection group sparsity representation, microarray gene expression
1 Introduction
Breast cancer is the second leading cancer among the women worldwide. It is
regarded as ahetero geneous group of diseases with complex and distinctive
underlying molecular pathogenesis [1]. Many of the new genomic analysis tools offer
great promise for classifications of tumors based on variations in gene expression.
2These techniques have been used to deep delineate tumor groups or to identify
candidate genes for tumor prognosis and therapeutic targeting. As such problems can
be viewed as classification ones, various classification methods have been applied to
analyze or interpret gene expression data resulting from DNA microarrays [2-3].
However, have the characteristics of small samples (patients), high dimensions
(thousands of genes) and high redundancy [4], which impose a challenge to tumor
classification.
Microarray gene expression data-based tumor classification mainly consists of
clustering [5] and classification [6]，Furey et al. [7] used support vector machine
(SVM). Shi et al. [8] proposed an improved diagonal discriminant analysis with
sparse constraint for tumor classification. The most common classifier algorithm used
to classify medical data is J48 decision tree for breast tumor. The serious drawbacks
of the decision tree algorithm are over fitting, complexity, cost. There are various
methods such as Boosting/Bagging to ensemble various classifiers and to provide the
efficient classification. Sparse representation-based classification (SRC) was
introduced by Wright et al. [9] for face recognition, in which the training images are
used as the dictionary to code an input testing samples as a sparse linear combination
of them via l1-norm minimization. Many scholars use SRC for gene expression
profiling data. Zheng et al. [10] made use of singular value decomposition to learn a
dictionary and then classified gene expression data of tumor subtypes based on SRC.
Gan et al. [12] improved and generalized [11] by adding a weighted matrix.
However, The sparse representation based classification (SRC) performs not very well
for small sample data. Yang et al. proposed an inverse projection based
pseudo-full-space representation classification (PFSRC) for face recognition [13] by
utilizing existing available samples rather constructing auxiliary training samples. The
PFSRC focused on exploiting complementary information between training samples
and test samples, for example, when a portion of an image is occluded, non-occluded
region of the same image still contains useful information for identification. However,
gene expression data do not have this complementarity. In the SRC and PFSRC based
methods, the dictionary is constructed by all training samples. The existing methods
3are all based on the information gene to do the follow-up work directly.
Recently, a new kind of matrix recovery, namely robust principal component
analysis (RPCA), RPCA is called Low rank, the RPCA proposed by Candes et al. can
recover a low rank matrix from highly corrupted measurements [15]. RPCA is the
most widely used method in the field of image processing [23], however, existing
methods focus on the low-rank part, the application of RPCA is rare in tumor
classification. Liu et al. propose a novel RPCA-based method for classifying tumor
samples [14]. For a special biological process, the expression profiles of most of the
genes are flat. All these genes are considered as non-differential expression. It is
natural to treat these data of non-differentially expressed genes as approximately low
rank. Only a small number of genes are relevant to a special biological process, so the
data of these differentially expressed genes can be treated as sparse perturbation
signals. RPCA is applied to extract a subset of genes associated with a special
biological process, they still use the information gene to make direct follow-up
recognition. For breast tumor, we should pay attention to the tumor lesion part and
normal part.
Deep-learning based classification methods have been proved effective for
recognition. It is noted that the success of deep-learning relies on big data, complex
net structure and advanced hardware. In this paper, we do not consider the method of
learning, but rather focus on an improvement from the mathematical model and
dictionary. According to the characteristics and group sparsity, we propose a new
inverse-projection group sparse representation based classification (IPGSR) and gives
the model solution. We use new thinking, the proposed low-rank variation dictionary
tackles tumor recognition problem from the viewpoint of detecting and using
variations in gene expression profiles of normal and patients, rather than directly
using these samples. We just focus on representation and classification, and adopt
simple gene selection method.
The remainder of this paper is organized as follows. The remainder of this paper is
organized as follows. The presented robust breast tumor classification based on
low-rank variation dictionary and IPGSRC is stated in Section 2. Extensive
4experimental results on breast tumor gene expression datasets are shown in Section 3.
Finally, section 4 concludes the paper.
2 Methodology
In this section, the methodology of the presented robust breast tumor
classification is described. Firstly, we consider weighted group sparse representation
of ideas, we put forward inverse projection group sparse representation model and
give the model solution. Moreover, we give the constructed of the variation
dictionary.
2.1 Sparse representation based on training samples dictionary
SRC assumes that each test sample can be linearly represented by sufficient
training samples from the same category [9]. The projection way of SRC is that each
test sample is projected into the corresponding training sample space.
Given sufficient training samples of the i -th object class, any test sample from the
same class will approximately lie in the linear span of the training samples associated
with object i . Denote the training samples of all k classes as the matrix
  1 11 2 1 2, , [ , , , ]CC nX X X X x x x    ，where the sub-matrix 1 2[ , , , ] ii d ni i ii nX x x x R  
stacks the training samples of class i . Then, the linear representation of a testing
sample y can be rewritten in terms of all training samples as:
0 ,y X z  (1)
where 0 is a sparse vector whose entries are zeros except those associated with the
i -th class，and dz R is a noise term with bounded energy 2|| || .z 
2.2 Pseudo-full-space representation based on training samples dictionary
SRC shows significant performance when there are enough available training
samples per subject. However, face recognition often suffers from insufficient training
samples. To tackle this problem, a novel classification technique is presented based on
utilizing existing available samples rather than constructing auxiliary training samples.
PFSR is stably and effectively exploit complementary information between samples.
PFSR aims to seek a representation space as large as possible. The training and test
5sample space are X and Y , respectively. If the space { X , Y } is called full space,
which contains all training samples and test samples. And then the space jV is the
largest representation space of a sample jx ,
{ , } .j jV X Y x 
It is quite natural that the jV is just the full space except the training sample
jx itself and called the pseudo-full-space of jx . jV Obviously, provides richer
information than the training sample space because of the addition of the test samples.
PFSR means that a training sample jx from a category i is represented by its
corresponding pseudo-full-space.
, 1 1 , 1 1 ,1 1 , .j i j j i j j j j k kx x x y y              (2)
where ,i s R  and ,j l R  are the corresponding coefficients before training samples
and test samples respectively, 1, 2, ,i C  , 1, 2, , Cj s  , 1, 2, , .l k  .
Let , 1 , 1 ,1 ,[ , , , , , , ]
T
j i j i j j j kA         , jixs can be rewritten as
.j j jx A V (3)
2.3 IPGSRC based on low-rank variation dictionary
2.3.1 Low rank model for gene expression data
For SR and PFSR method, they all use information genes as features for
classification. We are more concerned with the lesion part of the gene, in this paper,
we use the low-rank to construct a new dictionary. Furthermore, the new variation
dictionary has much sparse than the training samples. The proposed method tackles
tumor recognition problem from the viewpoint of detecting and using variations in
gene expression profiles of normal and patients, rather than directly using these
samples as conditional.
Considering the matrix X of gene expression data with size m n , each row
of X represents the transcriptional responses of a gene in all the n samples, and each
column of X represents the expression levels of all the m genes in one sample.
6Supposing that X is given by X XX L S  , 1 2 1 21 1[ , , , ] [ , , , ]C nCX X X X x x xS S S S s s s   .
Low rank solves the following optimization problem:
* 1
,
min || || || || ,
. . .
X X
X X
L S
X X
L S
s t X L S

 
(4)
where  is a positive regulation parameter, *|| || : ( )X i XiL L denotes the nuclear
norm of the matrix X , that is, the sum of its singular values, and
1|| || : | |ijX XijS S denotes the 1l -norm of XS .
A Lagrange multiplier is introduced to remove the equality constraint of the Low
rank problem in Eq.(4). According to [15]，the augmented Lagrange multiplier method
can be applied on the Lagrangian function:
2
* 1( , , , ) || || || || , || ||2X X X X X X X X F
L L S L S Y X L S X L S
          ,
where  is a positive scalar and 2|| . ||F denotes the Frobenius norm.
2.3.2 Variation dictionary by low rank (Fixed dictionary)
Low rank was originally proposed by Candes et al.[15], they goal of using low rank
to model gene expression data is to classify tumor samples based on the characteristic
genes that are identified by our method. However, they direct use of information
genes for subsequent identification, we are concerned about the changes in the breast
tumor, RPCA can decompose the observation matrix XL and give the sparse
perturbation matrix
1 2 1 2
1 1[ , , , ] [ , , , ]
C n
C
X X X X x x xS S S S s s s   . The genes corresponding
to non-zero entries in can be considered as ones of differential expression. Sparse
perturbation matrix XS is breast tumor variations in gene expression profiles of
normal and patients. So we construction of low-rank variation dictionary by sparse
perturbation signals.
2.3.3 Low-rank variation dictionary (Changing dictionary)
For other problems, such as: to determine whether there is a breast cancer and the
type of tumor, etc., in view of these problems, we construct a variable variation
dictionary, according to the training sample changes the variation dictionary. For the
7training samples, because of the known class labels, low-rank decomposition can be
performed with different types of samples (different classes can reflect the difference
of the samples to the sparse parts of the low-rank decomposition). For the test sample,
the test sample is low rank decomposed with the help of the existing training sample
(the training sample contains both the same type and the different type of the test
sample), because it does not know the class. The algorithm for constructing a
variation dictionary is similar to a fixed variation dictionary, we give the algorithm
flow of the variation dictionaries.
Algorithm 1:Variation dictionaries are constructed using the sparse parts of the low-rank
decomposition
Input: Training sample set   1 11 2 1 2, , [ , , , ]CC nX X X X x x x     ， and test sample
set  1 2, , , kY y y y  . k expresses the number of test samples.
Step 1: Given an appropriate parameter 1/ max( , )m n  ， where m the transcriptional
responses of a gene samples ， n represents the expression levels of all the m genes in one
sample.
Step 2: X XX L S  , Y YY L S  , where ,X YL L denote low-rank
matrix,
1 2 1 2
1 1[ , , , ] [ , , , ]
C n
C
X X X X x x xS S S S s s s   , 1 2, , , kY y y yS s s s    denote sparse perturbation
signals.
Output：variation dictionary
1 2 1 2
1 1[ , , , ] [ , , , ]
C n
C
X X X X x x xS S S S s s s   .
2.3.4 IPGSR based on low-rank variation dictionary
The PFSRC focused on exploiting complementary information between training
samples and test samples, for example, when a portion of an image is occluded,
non-occluded region of the same image still contains useful information for
identification. However, gene expression profiling data do not have this
complementarity with face, so we use the test sample space represent the training
samples, The new presentation space is called inverse projection representation. It is
known that encoding the group information in addition to sparsity will lead to better
signal recovery/feature selection. The 1,2l -regularization promotes group sparsity.
Combination of the group sparsity and the inverse projection representation, we
8proposed to inverse-projection group sparse representation (IPGSR).
IPGSR uses all the test samples to represent each training sample. The training and
test sample space are XS and YS , the linear representation of a testing sample j
i
xs
can be rewritten in terms of all variation dictionary as:
1,1 ,1 ,
.
j r k
i
x i y i y i k ys m s m s m s     (5)
where ,i rm R . Let ,1 ,[ ,..., ]Ti i i km m m , jixs can be rewritten as .jix Y is S m And
then all training samples can be linearly represented as follows.
,X YS S M （6）
where
1 1
[ , , ] [ , , ]
c
T k n
G G nM M M m m R
    is the projection coefficient matrix,
1 2
[ , , , ]
CX X X X
S S S S  variation dictionary.
(a) Sparse representation (b) PFSR
(c) IPGSR
Fig.1. Comparison of representations. (a) SR based on training samples dictionary; (b)PFSR based
on training samples dictionary; (c) IPGSR based on low-rank variation dictionary.
Comparing Eq. (2) and Eq. (5), IPGSR space has changed, comparing Eq. (1) and
eq. (5), IPGSR is just the opposite of the SR representation space.
2.3.5 Optimization of IPGSR model
The group sparsity in SR is done by vector, we consider the group sparsity of the
vector of variable selection. Therefore, the group sparse of the inverse projection
representation model is to do the matrix.
9The (weighted) ,2,1wl -regularization has been popularly used to encode the group
sparsity [5], given by
2
,2,1
1
min || || || || .
. . .
j
s
w j G F
M
j
Y X
M w M
s t S M S



 (7)
where m nXS R
 ,
1 1
[ , , ] [ , , ]
c
T k n
G G nM M M m m R
    , m kYS R  ,
2
21
1 1 1 2
|| || || || .
n m n
i
ij
i j i
M m m
  
    ,i jm m represent its i -th row and j -th column
respectively， 2|| ||
im denotes the 2l -norm of
im . , 1, ,im i n  is coefficient vector.
cppGp ,,1,  , denotes the number of categories.
The optimization problem can be solved by the ADMM [17]. The problem (7) can be
converted into an equivalent optimization problem as
, ,1,
1
min || || || || .
. . , .
j
s
w F j G F
M Z
j
Y X
Z w Z
s t S M S Z M


 
 (8)
Note that problem (8) has two blocks of variables ( M and Z ) and its objective
function is separable in the form of ( ) ( )f M g Z since it only involves Z , thus
ADDM is applicable. The augmented Lagrangian function of problem is defined by,
1 2
21
, 1 2 ,2,1 1
22
2
( , ; , ) || || , || ||
2
                                  , || || .
2
w F
Y X Y X F
L M Z Z Z M Z M
S M S S M S
 


       
    
where 1 2, ,
m n m nR R     are multipliers and 1 , 2 are penalty parameters.
The ADMM scheme takes the following form
1 2
1 2
, 1 2
, 1 2
1 1 1
1 2 2
arg min ( , ; , ),
arg min ( , ; , ),
( ),
( ).
A
Z
Y X
M L M Z
Z L M Z
Z M
S M S
 
 


           
Finally, we get the iteration formula
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1
1 2 1 1 2 2( ) ( ( ) ( ) ).T T
T T
Y Y XY Y
M I S S Z S S S          
2 21 2
, ,1 1 2,
min || || ( ) || || ( ) || || .
2 2
T T
w F F F
M Z
Z Z M Z M YM X YM X
         (9)
ForM ,
1 1 2 2( ) ( ) 0.
T T TI Z M Y Y YM X       
1 1 1 2 2 2 0.
T T T TI Z M Y Y YM Y X         
1 2 1 1 2 2( ) .
T T T TI Y Y M Z Y Y X        
1
1 2 1 1 2 2( ) ( ).
T T T TM I Y Y Z Y Y X         (10)
Minimizing (9) with respect to Z gives the following Z sub-problem:
Simple manipulation shows that (9) is equivalent to
21
2 1 2
1 1
1
min [ || || || ( ) || ] .
2G G G ii i i
s
i G
Z
i
w Z Z M
    
which has a closed form solution by the one-dimensional shrinkage (or soft
thresholding) formula:
1
max || || ,0
|| ||j
j j
G j F
j F
w
Z
  
    
. (11)
where
1
1
1
( )
j jj G G
M    .
and the convention 0 ∙
0
0
  0 is followed. We let the above group-wise shrinkage
operation be denoted by 1
1 1
1
( , ).
w
Z shrink M     for short.
Finally, the multipliers 1 and 2 are updated in the standard way
1 1 1 1
2 2 2 2
( ).
( ).Y X
Z M
S M S
 
 
   
   
where 1 2, 0   are step lengths.
In short, we have derived an ADDM iteration scheme for (8) as follows:
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Algorithm2：ADMM for IPGSR
Input: Training sample set
1 2 1 2
1 1[ , , , ] [ , , , ]
C n
C
X X X X x x xS S S S s s s   , test sample set
1 2
, , ,
kY y y y
S s s s    .
Initialize: Initialize 1 2,
n k m nR R    
,
0 0 =0M Z
, 1 2
0  ， ， 1 2, 0   .
Iterate until convergence:
1) 11 2 1 1 2 2( ) ( )T T
T T
Y Y XY Y
M I S S Z S S S          ;
2)
1
max ,0
j
j j
G j F
j F
w
Z
  
    
,
1
1
1
( )
j jj G G
M    ;
3) 1 1 1 1( )Z M     ；
4) 2 2 2 2( )Y XS M S     .
End while
Output:An optimal solution ,M Z .
2.3.6 Category contribution rate
From Figs.1, it can be also observed that the conventional classification criteria,
reconstruction error, doesn’t work for IPGSR. Since the representation dictionary is
unlabeled test samples. Hence, category contribution rate (CCR) is constructed to
match the proposed PFSRC [13] and complete classification. IPGSR using
classification criteria of CCR.
For a test sample
ry
s , the contribution rate ,j rC of rys for the j -th category can
be calculated by Eq.（12）
, 1,...,
,
, 1,...,
1,...,
({ } )1
.
{ }
j i r i n
j r
j i r i n
i n
m
C
s m
 


      
  （12）
where 1, 2, , , 1, 2, ,j c r k   , js denotes the number of j -th category training
samples.
The CCR matrix ,[ ], 1, 2, , , 1, 2, ,j rC j c r k   ,for all test samples is got.
Through the CCR, we can compare correlations between each test sample and every
category. The larger the CCR is, the higher the correlation is. A test sample
ry
s is
12
classified into the category with the maximal contribution rate , , 1, 2, ,j rC j c  .
,
{1, , }
arg max( )r j r
j c
u C



. (13)
By this means, categories of all test samples are obtained simultaneously and
classification can be completed.
2.3.7 Classification stability index
For the representation-based classification methods, suppose 1bestR and
2
bestR are
the values of a classification criterion corresponding to the best category and the
second best category. The CSI of a test samples is defined to measure the difference
between 1bestR and
2
bestR The CSI is normalized as [0,1]CSI  and is always
defined as the ratio of the smaller one and the larger one.
1
2
.best
best
R
CSI
R
 (14)
For SRC, the CSI is denoted as RECSI , where
1
bestR and
2
bestR are the minimal
reconstruction error and the second minim alone. While for IPRC, the CSI is denoted
as CCRCSI , where
1
bestR and
2
bestR are the second maximal CCR and the maximal
one.
By this way, a statistical measure, CSI, is defined qualify the classification stability
of representation‐based methods. The smaller the index is, the better the stability is,
the better the representation‐based method is. Detailed experiments will be shown in
Subsection 3.3.4.
2.4 Low-rank variation dictionary and IPGSRC model for breast tumor
Combined the low-rank variation dictionary with IPGSRC, the basic idea of our
robust breast tumor classification algorithm is as follows.
13
Fig. 2.Flow chart of the low rank variation dictionary and IPGSRC for robust breast tumor.
Algorithm3：Classification based on IPGSR.
Input：Low rank variation dictionary
1 2 1 2
1 1[ , , , ] [ , , , ]
C n
C
X X X X x x xS S S S s s s   the test sample
set
1 2
, , ,
kY y y y
S s s s    .
Step1. By Eq.（5）the inverse projection representation is realized.
Step2. By Eq. (10), the projection coefficient matrix is got.
Step3. By normalizing the CCR matrix, relevancies between each test sample and all categories
are obtained.
Output: By Eq. (13), each test sample can be classified into the category with the maximal CCR.
3 Experiments and discussions
In this section, effectiveness of our methods is demonstrated by extensive
experiments on public breast tumors gene expression datasets. The kinds of measures
are used to measure the performance of these methods. Accuracy measures the
classification performance by using the percentage of correctly classified samples.
Sensitivity measures the non-missed diagnosis performance by using the rate of
correctly classified positive samples. Specificity measures the non-misdiagnosis
performance by using the rate of correctly classified negative samples. For any test,
there is usually a trade-off between the sensitivity and specificity. This trade off can
be represented graphically using a receiver operating characteristic curve (ROC),
which is a graphical plot that illustrates the diagnostic ability of a binary classifier
system as its discrimination threshold is varied[18]. AUC is just the area under the
curve of ROC and is also suitable to binary classification problem. Error reduction
14
rate (ERR)[19] intuitively characterizes the proportion of the errors reduced by
switching a method to the other one. Without loss of generality, ten-fold
cross-validation ten times is used to test the performance of the algorithms. The
algorithm gives the convergence analysis and gene biological analysis.
All experiments are carried out using MATLAB R2016a on a 3.30GHz machine
with 4.00GB RAM.
3.1 Breast tumor datasets
This breast tumor [20] [21]study was first reported in (Van't Veer et al,2002). This
DNA microarray analysis on primary breast tumor of 25,000 gene expression
Measurements of 117 young patients. We selected 79 primary breast tumor: 34 from
patients who developed distant metastases within 5 years, 45 from patients who
continued to be disease-free after a period of at least 5 years, Breast-2: all 79 patients
were lymph node-negative, and 55 years old or younger. From each patient, tumor
size under 5 cm.
Breast-2(97) [25]: For the samples of 117 databases Van't Veer et al[21], about
25,000 genes. Many articles select samples for further analysis and classification
based on different indicators. Jiang et al. [25] Where 97 lymph node-negative breast
tumor patients, 55 years old or younger, participated in this study. Among them, 46
developed distant metastases within 5 years and 51 remained metastases free for at
least 5 years, which is reported as (Breast-2(97)).
Breast-1[24]: The purpose of the study is to classify female breast tumor patients
according to relapse and no relapse clinical outcomes using gene expression data. Fan
et al.[24] chose 77 samples on the basis of Van't Veer et al [21] .There were 44
developed distant metastases within 5 years and 33 remained metastases free for at
least 5 years, which is reported as (Breast-1).
Breast-3: Molecular Signature of Pregnancy Associated Breast Cancer (PABC),
Malignant epithelia and tumor-associated stroma of PABC and Non-PABC were
isolated by laser capture microdissection and gene expression profiled. Additionally,
normal breast epithelia and stroma adjacent to the two tumor types were profiled.
Series_supplementary_fileftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE31nnn/GSE31192
15
/suppl/GSE31192_RAW.tar.
For gene expression data, there are several simple ways to deal with missing values
such as deletingan expression vector with missing values from further analysis,
imputing missing values to zero, or imputing missing values of a certain gene (sample)
to the sample(gene) average (Alizadeh et al., 2000). In this article, we used this
method.
Table.1 Breast dataset
Data sets Class1 Class2 All Genes
Breast-1 33 44 78 4869
Breast-2 45（norm） 33(tumor) 79 21220
Breast-3 13（norm） 20(tumor) 33 54675
3.2 Performance of variation dictionary
3.2.1 Sparsity of variation dictionary
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Fig.3. Pseudo color image of the samples for the Breast-2 database, (a), (d) observation matrix
heat map, (b), (e) low-rank matrix heat map. (c), (f) variant dictionary matrix heat map.
In this experiment, for the breast tumor gene expression datasets, randomly select
some of the two categories of samples to put together for low rank decomposition, we
use the decomposition of the sparse part vector to construct a new variation dictionary.
Fig.3 mainly describes the sparsity of variation dictionary from the heat map. (a), (d)
observation matrix heat map ； (b), (e) low-rank matrix heat map; (c), (f) variant
dictionary matrix heat map; where transition from blue to red colors corresponds to a
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shift from low to high expression values of the samples. The vertical axis represents
samples (4 tumor samples, 4 normal samples) and the horizontal the genes arranged.
We use a sparsely constructed variation dictionary instead of the original gene
expression profile data. Variation dictionary can be considered as ones of differential
expression.
Matrix 0 0D A E  , analytic solution ( , )A E , real solution 0 0( , )A E , 0.0707  .
Table.2 The error, rank and sparseness of the output solution and the real solution in Breast-1 data.
iter
0
0
|| ||
|| ||
F
F
A A
A
 Rank( L )
0|| ||E
1 0.069465 69 3903
10 0.004144 66 7305
20 0.002572 54 8940
30 0.001442 48 9571
40 0.000851 44 9832
50 0.000484 43 9959
60 0.000298 41 10043
70 0.000210 41 10085
80 0.000165 40 10107
90 0.000132 40 10124
100 0.000107 40 10123
As can be seen from the experimental results, as the number of iterations increases,
the error and rank become smaller and smaller, and the output solution becomes more
and more sparse.
3.2.2 Comparison of variation dictionary and other dictionary
This section mainly introduces the contrast between our variation dictionary and
ESRC[9] average sample variation dictionary, IPGSRC comparison of three
classification methods. The Breast-2 datasets, our method first screened for 200 genes
with SNR[22]. The data is then equally divided into ten categories based on the class
labels, of which nine are put together to construct a variation dictionary using
low-rank decomposition and the other one is put together for low-rank decomposition
and the sparse fraction is used as a test.
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Table.3 Comparison of different dictionaries of breast tumor.
Method SRC GSRC IPRC IPGSRC
Our method 66.67% 77.78% 77.78% 88.89%
Average
dictionary
55.56% 55.56% 55.56% 66.67%
Table.4 Sensitivity and specificity of different classifiers.
Method SRC GSRC IPRC IPGSRC
Sensitivity 50% 50% 75% 75%
Specificity 80% 100% 80% 100%
AUC 0.90 1 0.65 1
From Table.3 and Table.4, we can see from the recognition rate, the sensitivity and
specificity that the our method is better.
The current clinical manifestations of breast tumor, the specificity is relatively low,
that is, the misdiagnosis rate is relatively high, the breast tumor misdiagnosed as
breast hyperplasia, breast fibroids are still recurring, delayed treatment, seriously
affecting the patient's survival time. Breast tumor misdiagnosed line local excision
may have adverse consequences and all malignant tumors, the first time the correct
treatment of local breast tumor and reasonable treatment is an important part of good
effect, inappropriate local treatment may bring the some patients Dangerous. Visible
high misdiagnosis, then the cost is relatively large, and our specificity of this method
to 100%, that is misdiagnosis rate of 0.
3.3 Results of breast tumor classification based on variation dictionary and
IPGSR
This part focuses on description IPGSRC convergence analysis, the performance of
IPGSRC is also compared with the latest method based sparse representation for
breast tumor classification. The compared methods are IPSRC, GSRC, SRC.
3.3.1 Convergence analysis
In this section, the convergence of IPGSRC model is analyzed. Fig.4 represent
algorithms ADMM iterative error chart for solving IPGSRC model, where Fig.4 (a)
the iteration error chart between exact solution and iterative solution, Fig.4 (b) the
iteration error chart between adjacent iterations. We can be seen from the Fig.4 that
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the overall trend of the error of the algorithm is decreasing and tends to zero,
indicating that the algorithm of ADMM is convergence.
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Fig.4. Convergence analysis IPGSRC model. (a) IPGSRC the iteration error chart. (b) The
error between two adjacent iterative solutions.
3.3.2 Comparison of IPGSRC and other classification
The performance of IPGSRC for robust breast tumor classification is demonstrated
in this subsection. For comparison, the results of IPRC 、GSRC and SRC are listed
under the same experimental environment.
The classification results, accuracy, sensitivity, specificity and AUC are listed in
Table 5. For the two binary datasets, ROCs are drawn to further study the trade off
between sensitivity and specificity of the approaches (Fig.5). For each experiment, we
run the ten-fold cross validation ten times and take the means as the final results.
Table.5 and Fig.5 show that IPGSRC achieves competitive results with highest AUC,
which shows IPGSRC has the best prediction ability among the three classifiers. ROC
plot analysis in Fig.5 has shown that IPGSRC has the better discrimination ability
than IPRC、GSRC and SRC. The accuracy of IPGSRC are higher than IPRC、GSRC
and SRC on Breast-2 dataset.
More intuitively, ERR is introduced to demonstrate that our method is superior to
latest articles.
1 2
1
100%
ER ER
ERR
ER
  ,
where 1ER is the error rate of the latest article classification result, 2ER is the error
19
rate of our method classification result, ERR is denoted by a notion ↓. Table.5 lists
the error reduction results by switching SRC to IPRC on Breast-2 datasets. Table.5
show that since the IPGRC reduces the error rate from 29.56% to 11.37%, the ERR is
61.54% [(29.56-11.37)/29.56], suggesting that 61.54% recognition errors can be
avoided by using IPSRC instead of SRC.
Table.5 Breast-2 datasets.
Method Accuracy Error rate ERR
IPGSRC+300 88.63% 11.37 -
IPRC+300 73.21% 26.79  57.55%
GSRC+300 71.90% 28.10  59.54%
SRC+300 70.44% 29.56  61.54%
IPGSRC+1000 91.49% 8.51 -
IPRC+1000 88.02% 11.98  28.96%
GSRC+1000 85.24% 14.76  42.34%
SRC+1000 84.13% 15.87  46.38%
Table.6 Breast-3 data identification rate 100 average.
methods IPRC+200 IPRC+200 IPGSRC+200 GSRC+200 SRC+200
accuracy 99.75% 99.67% 100% 99.67% 99.33%
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Fig.5. ROC analysis of the ability of SRC, GSRC, IPRC and IPGSRC on Breast-2 datasets. Note
that on the vertical axis, the scale is from no (0) to complete (1 or 100%) sensitivity. The
horizontal axis is a reciprocal scale (1-specificity). The optimum performance of a test is
determined either as the highest sum of the specificity and sensitivity or at an acceptable level of
sensitivity for the given disease.
20
Table.7 The AUC area corresponding to the ROC curve of different classifiers.
Method IPRC SRC GSRC IPGSRC
AUC 91.63 90.00 89.67 0.9353
Box plots of error rates are shown in Fig.6 after performing ten-fold cross
validation. Fig.6 illustrates that SRC, GSRC, IPRC and IPGSRC achieve average
error rates (red line) of 27%, 25.5%, 25.9%, 22.3% on Breast-2 datasets. Overall, a
robust result with relatively low error rate can be offered by representation based
methods.
SRC GSRC IPRC IPGSRC
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Fig.6. Box plots for error rates of four classifiers, The box characterizes the distribution of error
rate. Namely, box's location and scale indicate the median (red lines) and interquartile range (blue
box), respectively.
3.3.3 Comparison of Category Contribution Rate and Reconstruction Error
Next, we demonstrate CCR for IPRC is superior to reconstruction error for SRC.
First, we should notice the fact that the more obvious the difference between
categories is, the stronger the discrimination ability is, and the better the classification
criterion is. Figs. 7 and 8 give the results of the two criterions about some randomly
selected test samples. The same color expresses the values of a test sample across all
categories. According to the overall trend, one can see that, to the same test sample,
difference between categories of CCR is much bigger than that of reconstruction error.
This shows that the CCR has better discrimination power than construction error.
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(a) IPGSRC (b) IPRC (c) GSRC (d) SRC
Fig.7. The comparison of nine samples random selected on Breast-2 datasets. (a),(b) CCR, (c),(d)
Reconstruction error. The same color histogram expresses the same category.
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Fig.8. The comparison on Breast_2 dataset. (a),(b) CCR. (c),(d) Reconstruction error. This
3-dimensional histogram shows the values of two classification criterions of test samples across
all classes. The same color expresses the values of the same test sample across all categories.
3.3.4 Results of classification stability
Next the classification stability is further verified by comparing the quantitative
indicator of stability, CSI. Fig.9 shows the CSI of all samples on the Breast-2 datasets.
The smaller the CSI is, the better the stability is. One can see that RECSI is almost
close to 1 in all subfigures, while the CCRCSI is much smaller. That is to say, the
difference between 1bestR and
2
bestR in CCR for IPGSRC is much bigger than those in
reconstruction error for SRC. This further verifies CCR for IPGSRC has better.
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Fig.9. The curve of CSI versus all samples in ten-fold cross validation. The red line expresses
CSIs of CCR in IPGSRC, green line expresses CSIs of CCR in IPRC, blue line expresses CSIs of
reconstruction error in SRC+G, and purple line expresses CSIs reconstruction error in SRC. The
smaller the CSI is, the more stable the representation is.
3.3.5 Comparing with state-of-the-art methods
This part explores the classification results of breast tumors based on the
Breast-2(97), Breast-1database in recent years compared with the classification results
of this article. Table 8 shows that on the Breast-2 (97) dataset, the latest articles in
recent years use 10-fold cross validation, the highest accuracy was 87.4%. Our
method in the same dataset and same environment, the accuracy was 87.1%. Table
9shows that on the Breast-1 dataset, the latest articles in recent years the highest
accuracy was 80.03%. Our method in the same dataset and same environment, the
accuracy was 80.81%, 0.78% above the highest accuracy.
Table 8 and 9 show that our method classification performance is better than latest
classification results. For Breast-2(97) dataset, although the results of the method are
higher than ours, Su et al. still start from the perspective of information genes, we use
new thinking, from the viewpoint of detecting and using variations in gene expression
profiles of normal and patients, rather than directly using these samples.
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Table.8 Classification accuracies based on different methods on Breast-2(97).
Methods Accuracy(%)
Jiang et al.(2017) 80
Su et al.(2017) 87.4
Our method 87.1
Table.9 Classification accuracies based on different methods on Breast-1.
Methods Error Rate（%） ERR(%)
Our method 19.19 -
Zhang et al.(2017) 20 ↓4.05
Fan et al.(2015) 19.97 ↓3.91
4 Analysis of candidate’s pathogenic genes
Apart from obtaining high classification accuracy results, it is also important to
identify pathogenicity-related genes, which can be a biomarker of early diagnosis and
be helpful to auxiliary diagnosis. Pathogenicity-related genes selected in this article
are decision information genes. Firstly, the basic biological attribute description of the
decision information genes for classification is given, and then the specific biological
description and rationality verification of some selected decision information genes
are given.
4.1 Gene biology analysis
4.1.1 Gene enrichment analysis
To further study the biological function of the candidate pathogenicity-related
genes. We first selected 300 genes from the SNR gene. We also perform the functional
enrichment analysis of the top 300 genes identified by our method on the website
https://david.ncifcrf.gov/. The results of KEEG_PATHWAY are listed in Table 10. It
can be seen from Table.10 that the item of metabolic pathways has the lowest p-value,
so it is considered as the most probable enrichment item. Only this pathway has
statistical meaning( p<0.05 ). For genes enrich by our method from Breast-2 data, we
further do Kaplan-Meier curve by anglicizing survival curves and corresponding
Log-Rank p values on the website http://www.oncolnc.org and
http://ualcan.path.uab.edu/index.html. It can be seen from this Table.11 that there are
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six genes with statistical meaning (p<0.05), five are proto-oncogenes and one
anti-oncogene. On Fig.10 we show the survival curve of 2 genes. From Fig.13, we can
know that PGK1 (p=2.58e-06) is anti-oncogene, IP6K2 (p=0.0244) is proto-oncogenes.
For the two genes, high expression and low expression have significant difference in
survival rate.
Similar to Breast-2 data, on Breast-3 data used SNR for preliminary gene screening
of 200 genes. We also perform the functional enrichment analysis of the top 200 genes
identified by our method. The results of KEEG_PATHWAY are 55 genes (P <0.05 in
the gene pathway). For genes enrich by our method from Breast-3 data, we further do
Kaplan-Meier curve by anglicizing survival curves and corresponding Log-Rank p
values. It can be seen from this Table.12 that there are 2 are proto-oncogenes. On
Fig.11 we show the survival curve of two genes.
Table.10 KEEG-PATHWAY terms enrichment analysis of the top 300 genes in the Breast-2
data set by DAVID
Rank KEGG_PATHWAY P-Value
1 Pyrimidine metabolism 6.9e-3
2 Oocyte meiosis 8.4e-3
3 Metabolic pathways 1.0e-2
4 Cell cycle 1.4e-2
5 Glutathione metabolism 2.1e-2
6 Phosphatidylinositol signaling system 2.6e-2
7 p53 signaling pathway 4.2e-2
8 Purine metabolism 5.3e-2
9 Progesterone-mediated oocyte maturation 7.9e-2
10 Fatty acid degradation 9.2e-2
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Table.11 Proto-oncogenes and anti-oncogene searched by TCGA
Gene name P-Value Gene Genebank_Accession
CTPS1 0.046 Proto-oncogene 1503
GMPS 0.0215 Proto-oncogene 8833
PGK1 2.58E-06 Proto-oncogene 5230
PGAM1 0.0168 Proto-oncogene 5223
CCNB2 0.0376 Proto-oncogene 9133
IP6K2 0.0244 anti-oncogene 51447
Table.12 Proto-oncogenes and anti-oncogene searched the 26 genes in the Breast-3 data set
by TCGA
Gene name Genebank_Accession P-Value Gene
SFRP1 6422 0.00486 Proto-oncogene
NTRK2 4915 0.00796 Proto-oncogene
Fig.10. Kaplan-Meier survival curves of genes which enrich in pathways with statistical mearning
( 0.05p  ). Subimages from left to right: PGK1and IP6K2 respectively.
Fig.11. Kaplan-Meier survival curves of the genes in the Breast-3 data set by TCGA which
enrich in pathways with statistical meaning ( 0.05p  ). Subimages from left to right: SFRP1and
NTRK2 respectively. Red lines denote upper 50% percentile and blue lines denote lower 50%
percentile.
4.1.2 Analysis of candidate’s pathogenic genes
In order to check the quality of the selection processes, the expression profiles of
the final identified genes for the opposite category are analyzed. For comparison, two
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irrelevant genes chosen randomly are presented. Fig.12 illustrates the two exemplary
expression levels of the patients for the pathogenic gene (CTPS1、GMPS、PGK1、
PGAM1 、 CCNB2 and IP6K2) listed in Table 11 and four irrelevant genes
(NM_014670andContig25583_RC). In Fig.12, the red line denotes gene expression
levels of 45 normal samples and the blue line expresses gene expression levels of
34tumor samples. The line indicates the mean values of gene expression levels in
corresponding class. One can see in both cases the mean value of the samples
belonging to breast tumor category differs significantly from the referenced (normal)
category.
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Fig.12.Comparison of expression levels for the pathogenic genes (a, b, c, d, e, f, g, h) and
irrelevant genes (g, h). For pathogenic genesCTPS1, GMPS, PGK1, PGAM1, CCNB2 and IP6K2,
the mean and standard deviation of expression levels about tumor category samples are higher
than that of normal category samples. But for irrelevant genes NM_014670 and Contig25583_RC,
they have similar mean and std in both categories.
Further more vividly illustrate the results of this article, Fig.14 shows the image of
the expression profiles for the two pathogenic genes (CCNB2 and IP6K2) and two
irrelative genes in the form of the colormap of jet, where transition from blue to red
colors corresponds to a shift from low to high expression values of the samples. The
vertical axis represents samples. Fig.12 and Fig.13 demonstrate that moderate to high
up regulation of TSPYL5 and ATP5J and down regulation for other two genes can
indicate the presence of Breast tumor distant metastases. There is a visible difference
between samples of the Breast tumor group and the reference one in TSPYL5 and
ATP5J but similar expression levels in PTPN1 and ATP2C2-AS1, which confirms
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good performance of the proposed gene selection procedure.
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Fig.13 Scatter plots of two identified genes and two irrelative genes on Breast-2 datasets.
Each panel corresponds to one gene. The red and blue colors correspond to normal and tumor
types respectively. (a, b, c, d, e, f) pathogenic genes (CTPS1, GMPS, PGK1, PGAM1, CCNB2
and IP6K2), and (g, h) NM_014670 and Contig25583_RC are equally expressed for tumor and
normal.
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Fig.14.Pseudo color image of the samples for the Breast-2 datasets. Each panel corresponds to one
gene. Blue to red colors represents low to high expression levels of samples. The image reveals
that moderate to high up regulation of CCNB2 and IP6K2 and down regulation for other two
genes can signal Breast-2.
4.2 Biological Description
PGK1 biological description: one, Data suggest that, in breast tumor cells, MYC
acts as an upstream regulator leading to PGK1 activation. (MYC, proto-oncogene
c-myc; PGK1, phosphoglycerate kinase 1).Two, results show that PGK1 mRNA and
protein expression were significantly increased in breast tumor tissues and can be
considered as a prognostic biomarker of chemoresistance to paclitaxel treatment in
breast tumor.
IP6K2 biological description: In yeast, IP6K plays a role in modulating telomere
length, soHSP90:IP6K2 interaction may also be anew target for controlling
telomerelength in tumor cells. The ability ofHSP90 to inhibit the normal growth
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regulatory activity of IP6K2 may be a segueinto the discovery of several similar
interactions.
PGAM1 is an enzyme involved in glycolysis and may play a role in the metabolism
and proliferation of tumor cells. PGAM1 is highly expressed in tumor cells. PGAM1
mRNA is expressed in both astrocytes and c6 glioma cells. Expression was
significantly higher in C6 glioma cells than in astrocytes. It was hypothesized that
PGAM1 mRNA plays a role in the malignant growth of gliomas. The expression of
PGAM1 protein in gliomas is significantly higher. Peri-tumoral tissue further
demonstrated that PGAM1 is associated with the malignant growth of gliomas. It
fully suggests that PGAM1 is expected to become a new tumor marker and
therapeutic target for gliomas.
CTPS1 biological description: Deficiency in cytidine 5-prime triphosphate synthase
1 (CTPS1) causes a combined immunodeficiency affecting both cellular and humoral
immunity. CTPS1, one of two mammalian CTP synthases (the other being CTPS2),
catalyzes the formation of CTP, an essential nucleotide for DNA and RNA synthesis .
Lymphocytes from patients with CTPS1 deficiency have reduced intracellular levels
of CTP, which suggests a defect in protein stability. The diagnosis of CTPS1
deficiency is difficult. Patients can have a relatively normal immunologic workup,
especially in the absence of chronic EBV infection .
5 Conclusions and future work
In this paper, an inverse-projection group sparse representation model is presented
for breast tumor classification, which is based on constructing low-rank variation
dictionary. The proposed low-rank variation dictionary tackles tumor recognition
problem from the viewpoint of detecting and using variations in gene expression
profiles of normal and patients, rather than directly using these samples. The inverse
projection group sparsity representation model is constructed based on taking full
using of exist samples and group effect of microarray gene data.
Furthermore, some valuable analysis of candidate pathogenicity-related genes is
given. There remain some interesting questions. One is how to enforce some prior
constraints into the IPGRC model and construct gene network. Another is gene
29
selection and its biological meanings.
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